Equities

Shanghai Jiaoda Onlly Co Ltd

600530:SHH

Shanghai Jiaoda Onlly Co Ltd

Actions
Consumer Staples Food Producers
  • Price (CNY)2.19
  • Today's Change-0.05 / -2.23%
  • Shares traded8.38m
  • 1 Year change--
  • Beta0.6745
Data delayed at least 15 minutes, as of Jun 07 2024 08:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SHANGHAI JIAODA ONLLY CO., LTD is a China-based company principally engaged in the development, production and distribution of healthcare products. The Company is also engaged in commerce, property and leasing businesses. The Company mainly provides microbial agents and herbal preparations under the ONLLY brand, nutritional supplements under the Natural Elements brand, and Chinese traditional tonic under the Onlly Pure brand. The Company is also engaged in sales agent business. The Company conducts its businesses primarily in Shanghai and other regions, China.

  • Revenue in CNY (TTM)280.54m
  • Net income in CNY-39.86m
  • Incorporated1997
  • Employees935.00
  • Location
    Shanghai Jiaoda Onlly Co Ltd11F, Building 13, No. 99 Tianzhou RoadSHANGHAI 200233ChinaCHN
  • Phone+86 2 154277865
  • Fax+86 2 154277820
  • Websitehttp://www.onlly.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zhejiang Shengda Bio-pharm Co Ltd742.96m-53.74m1.78bn1.03k--1.42--2.40-0.3325-0.33254.277.310.44092.336.08719,919.20-3.103.39-3.714.4215.0328.58-7.027.571.41--0.226839.98-1.448.10-271.70--11.22-6.89
Jiangsu gdk Biotechnology Co Ltd33.39m-128.83m1.88bn451.00--1.40--56.42-1.04-1.040.268610.950.01930.41850.152974,034.57-7.453.30-8.734.8451.1475.56-385.8312.583.20--0.04832.60-57.74---270.88--54.07--
Shanghai Jiaoda Onlly Co Ltd280.54m-39.86m1.92bn935.00--6.59--6.85-0.0514-0.05140.3620.37610.34755.154.63300,042.20-4.64-7.62-7.62-10.7018.0340.06-13.36-27.010.6301-1.400.3455---21.432.6592.96---34.81--
Shanghai Shen Lian Biomedical Corp307.69m13.44m1.97bn380.00146.301.32--6.390.03270.03270.74933.620.19270.93551.06809,719.500.67985.390.71875.8466.1277.453.5325.486.16--0.000838.49-8.251.85-48.41-18.4910.47--
Data as of Jun 07 2024. Currency figures normalised to Shanghai Jiaoda Onlly Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Gfund Management Co., Ltd.as of 31 Dec 20230.000.00%
Great Wall Fund Management Co., Ltd.as of 31 Dec 20230.000.00%
Zhong Ou Asset Management Co., Ltdas of 31 Dec 20230.000.00%
Sealand Securities Co., Ltd. (Investment Management)as of 31 Dec 20230.000.00%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.